Imaging Studies in Substance Abuse

  • N. D. Volkow
  • J. S. Fowler
  • G.-J. Wang

Abstract

Imaging technologies developed over the past 15–20 years such as positron emission tomography (PET), single photon emission computed tomography (SPECT), and magnetic resonance imaging (MRI) have bridged the gap between the basic neurosciences and clinical research. Their application to the investigation of substance abuse has allowed pharmacological mechanisms that pertain to the reinforcing and toxic properties of drugs abuse and the brain metabolic and neurochemical changes associated with addiction to be investigated directly in the human brain.

Keywords

Toxicity Dopamine Nicotine Schizophrenia Caffeine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abi-Dargham A, Lamelle M, Seibyl J, Rattner Z, Baldwin RM, Zoghbi SS, Zea-Ponce Y. Bremner JD, Hyde TM, Charney DS, Hoffer PB, Innis RB (1994) SPECT measurement of benzodiazepine receptors in human brain with iodine-iomazenil: kinetic and equilibrium paradigms. J Nucl Med 35: 228–239PubMedGoogle Scholar
  2. Andrew RF (1994) Introduction to nuclear magnetic resonance. In: Gillies RJ (ed) NMR in physiology and biomedicine. Academic, San Diego, pp 1–24Google Scholar
  3. Barkley RA (1977) A review of stimulant drug research with hyperactive children. J Child Psychol Psychiatry 8: 137–165CrossRefGoogle Scholar
  4. Baxter LR, Phelps ME, Mazziotta J, Guze BH, Schwartz JM, Selin CE (1987) Local cerebral glucose metabolic rates in obsessive compulsive disorder: a comparison with rates in unipolar depression and normal controls. Arch Gen Psychiatry 44: 211–218CrossRefPubMedGoogle Scholar
  5. Baxter LR Jr, Schwartz JM, Phelps ME et al (1988) Localization of neurochemical effects of cocaine and other stimulants in the human brain. J Clin Psychiatry 49: 23–26PubMedGoogle Scholar
  6. Bergstrom M, Nordberg A, Lunell E, Antoni G, Langstrom B (1995) Regional deposition of inhaled HC-nicotine vapor in the human airway as visualized by positron emission tomography. Clin Pharmacol Ther 57: 309–317CrossRefPubMedGoogle Scholar
  7. Boag F, Havard CWH (1985) Cardiac arrhythmia and myocardial ischaemia related to cocaine and alcohol consumption. Postgrad Med J 61: 997–999CrossRefPubMedGoogle Scholar
  8. Braestrup C, Albrechsten R, Squires RF (1977) High densities of benzodiazepine receptors in human cortical areas. Nature 269: 702–704CrossRefPubMedGoogle Scholar
  9. Brodai A (1981) Neurological anatomy. Oxford University Press, New YorkGoogle Scholar
  10. Buchsbaum MS, Wu J, Haier R, Hazlett E, Ball R, Katz M, Sokolski K, Lagunas-Solar M, Langer D (1987) Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder. Life Sci 40: 2393–2400CrossRefPubMedGoogle Scholar
  11. Cameron OG, Modell JG, Hariharan M (1990) Caffeine and human cerebral blood flow: a positron emission tomography study. Life Sci 47: 1141–1146CrossRefPubMedGoogle Scholar
  12. Childress AR, Mozley D, Fitzgerald J, Reivich M, Jaggi J, O’Brien CP (1995) Limbic activation during cue-induced cocaine craving. Abstr Soc Neurosci 767.1Google Scholar
  13. *Dachis CA, Gold MS (1985) New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 9: 469–477CrossRefGoogle Scholar
  14. Derety J, Sjoholm H, Ryding E, Stenberg G, Ingvar D (1990) The cerebellum participates in mental activity: tomographic measurements of regional cerebral blood flow. Brain Res 535: 313–317CrossRefGoogle Scholar
  15. DeWit H, Metz J, Wagner N, Cooper M (1990) Behavioral and subjective effects of ethanol: relationship to cerebral metabolism using PET. Alcohol Clin Exp Res 14: 482–489CrossRefPubMedGoogle Scholar
  16. DeWit H, Metz J, Wagner N, Cooper M (1991) Effects of diazepam on cerebral metabolism and mood in normal volunteers. Neurospyschopharmacology 5: 33–41Google Scholar
  17. Eccles JC (1973) The cerebellum as a computer: patterns in space and time. J Physiol 229: 1–32PubMedGoogle Scholar
  18. *Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, MacGregor RR, Hitzemann R, Logan J, Bendriem B, Christman D (1989) Mapping cocaine binding in human and baboon brain in vivo. Synapse 4: 371–377CrossRefPubMedGoogle Scholar
  19. Fowler JS, Volkow ND, MacGregor RR, Logan J, Dewey SL, Gatley S J, Wolf AP (1992a) Comparative PET studies of the kinetics and distribution of cocaine and cocaethylene in baboon brain. Synapse 12: 220–227CrossRefPubMedGoogle Scholar
  20. Fowler JS, Volkow ND, Logan J, MacGregor RR, Wang G-J, Wolf AP (1992b) Alcohol intoxication does not change cocaine pharmacokinetics in human brain and heart. Synapse 12: 228–235CrossRefPubMedGoogle Scholar
  21. Fowler JS, Ding YS, Volkow N, Martin T, Mac Gregor R, Dewey SL, King P, Pappas N, Alexoff D, Shea C, Gatley J, Schlyer D, Wolf A (1994) PET studies of cocaine inhibition of the myocardial norepinephrine uptake. Synapse 16: 312–317CrossRefPubMedGoogle Scholar
  22. *Fowler JS, Volkow ND, Wang G-J, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Wolf AP, Warner D, Zezulkova I, Cilento R (1996) Inhibition of MAO B in the brains of smokers. Nature 379: 733–736CrossRefPubMedGoogle Scholar
  23. Frost JJ, Wagner HN, Dannals RF, Ravert HT, Links JM, Wilson AA, Burns HD, Wong DF, McPherson RW, Rosenbaum AE, Kuhar MJ, Snyder SH (1985) Imaging opiate receptors in the human brain by positron tomography. J Comp Assist Tomogr 9: 231–236CrossRefGoogle Scholar
  24. Galynker I, Schlyer DJ, Dewey SL, Fowler JS, Logan J, Gatley SJ, MacGregor RR, Ferrieri RA, Holland MJ, Brodie J, Simon E, Wolf AP (1996) Opioid receptor imaging and displacement studies with [6-0-[l1C]methyl]-buprenorphine in baboon brain. Nucl Med Biol 23(3): 325–331CrossRefPubMedGoogle Scholar
  25. Gatley SJ, Gifford A, Makriyannis A, Volkow ND (1996) Iodinelabeled AM 251: a radioiodinated ligand with binding in vivo to mouse brain CB1 cannabinoid receptors. Eur J Pharmacol 307: 331–338CrossRefPubMedGoogle Scholar
  26. Goodman LS, Gilman A (1990) The pharmacological basis of therapeutics, 8th edn. Pergamon, New York, p 549Google Scholar
  27. Grant BF, Harford TC (1990) Concurrent and simultaneous use of alcohol with cocaine: results of national survey. Drug Alcohol Depend 25: 97–104CrossRefPubMedGoogle Scholar
  28. Hartvig P, Bergström K, Lindberg B, Lundberg PO, Lundqvist H, Langström B, Svärd H, Rane A (1984) Kinetics of nC-labeled opiates in the brain of rhesus monkeys. J Pharmacol Exp Ther 230: 250–255PubMedGoogle Scholar
  29. Hearn WL, Rose S, Wagner J, Ciarleglio A, Mash DC (1991a) Cocaethylene is more potent than cocaine in mediating lethality. Pharmacol Biochem Behav 39: 531–533CrossRefPubMedGoogle Scholar
  30. Hearn WL, Flynn DD, Hirne GW, Rose S, Cofino JC, Mantero-Atienza E, Wetli CV, Mash DC (1991b) Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. J Neurochem 56: 698–701CrossRefPubMedGoogle Scholar
  31. Herkenham M, Lynn A B, Little MD, Ross Johnson M, Melvin LS, DeCosta BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87: 1932–1936CrossRefPubMedGoogle Scholar
  32. Hietala J, West C, Syvälahti E, Nagren Leikoinen P, Sonninen P, Ruotsalainen U (1994) Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology 116: 285–290CrossRefPubMedGoogle Scholar
  33. Howlett AC, Champion TM, Wilken GH, Mechoulam R (1990) Stereochemical effects of 11-OH 8 delta tetrahydrocannabinol-dimethylneptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor. Neuropharmacology 29: 161–165CrossRefPubMedGoogle Scholar
  34. Kessler RM, Parker ES, Clark CM (1984) Regional cerebral glucose metabolism in patients with alcoholic Korsakoff s syndrome. Soc Neurosci (Abstr) 10: 541Google Scholar
  35. Kolb B (1977) Studies on the caudate putamen and the dorsomedial thalamic nucleus: implications for mammalian frontal lobe function. Physiol Behav 18: 237–244CrossRefPubMedGoogle Scholar
  36. Kung HF (1993) SPECT and PET ligands for CNS imaging. Neurotransmissions 9: 1–8Google Scholar
  37. Laruelle M, Abi-Dargham A, van Dick C et al. (1995) SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med 36: 1182–1190PubMedGoogle Scholar
  38. **Le Moal M, Simon H (1991) Mesocorticolimbic dopaminergic network: functional and regulatory notes. Physiol Rev 71: 155–234PubMedGoogle Scholar
  39. Levin JM, Holman BL, Mendelson JH, Teoh SK, Garada B, Johnson KA, Springer S (1994) Gender differences in cerebral perfusion in cocaine abuse: technetium-m-HMPAO SPECT study of drug-abusing women. J Nucl Med 35: 1902–1909PubMedGoogle Scholar
  40. Levin JM, Mendelson JH, Holman LB, Teoh SK, Garada B, Schwartz RB, Mello NK (1995) Improved regional cerebral blood flow in chronic cocaine polydrug users treated with buprenorphine. J Nucl Med 36: 1211–1215PubMedGoogle Scholar
  41. Litton JE, Neiman J, Pauli S, Farde L, Hindmarsh T, Halldin C, Sedvall G (1993) PET analysis of [HC]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls. Psych Res 1–13Google Scholar
  42. Lofti J, Meyer JS (1989) Cerebral hemodynamics and metabolic effects of chronic alcoholism. Cerebrovasc Brain Metab Rev 1: 2–25Google Scholar
  43. London ED, Morgan JM (1993) Positron emission tomographic studies on the acute effects of psychoactive drugs on brain metabolism and mood. In: London ED (ed) Imaging drug action in the brain. CRC Press, Boca Raton, pp 265–280Google Scholar
  44. London ED, Broussolle EPM, Links JM, Wong DF, Cascella NG, Dannals RF, Sano M, Herning R, Snyder FR, Rippetoe LR, Toung TJK, Jaffe JH, Wagner HN Jr (1990a) Morphineinduced metabolic changes in human brain: studies with positron emission tomography and [fluorine-18]fluorodeoxyglucose. Arch Gen Psychiatry 47: 73–81CrossRefPubMedGoogle Scholar
  45. London ED, Cascella NG, Wong DF, Phillips RL, Dannals RF, Links JM, Herning R, Grayson R, Jaffe JH, Wagner HN (1990b) Cocaine induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]fluorodeoxyglucose. Arch Gen Psychiatry 47: 567–574CrossRefPubMedGoogle Scholar
  46. Marciniak G, Charalambous A, Schiue CY, Dewey SL, Schlyer DJ, Makriyannis A, Wolf AP (1990) 18F labelled tetrahydrocannabinol: synthesis, distribution in mice and PET studies in a baboon. J Nucl Med 31: 902Google Scholar
  47. Martin BR (1986) Cellular effects of cannabinoids. Pharmacol Rev 38: 45–74PubMedGoogle Scholar
  48. Mathew RJ, Wilson WH (1991) Substance abuse and cerebral blood flow. Am J Psychiatry 148: 292–305PubMedGoogle Scholar
  49. Mathew RJ, Wilson WH, Tant SR (1989) Acute changes in cerebral blood flow associated with marijuana smoking. Acta Psychiatr Scand 79: 118CrossRefPubMedGoogle Scholar
  50. Mazière M, Comar D, Marazano C, Berger G (1976) Nicotine-11C: synthesis and distribution kinetics in animals. Eur J Nucl Med 1: 255–258CrossRefPubMedGoogle Scholar
  51. Melon PG, DeGrado TR, Nguyen N, Caraher J, Tooronagian SA, Hutchins GD, Schwaiger M (1992) Non-invasive assessment of regional myocardial sympathetic neuronal function following intravenous cocaine injection in dogs. J Nucl Med 33: 994Google Scholar
  52. Meyer JS, Sakai F, Karacan I, Derman S, Yamamoto M (1980) Sleep apnea, narcolepsy, and dreaming: regional cerebral hemodynamics. Ann Neurol 7: 479–485CrossRefPubMedGoogle Scholar
  53. **Mullani NA, Volkow ND (1992) Positron emission tomography instrumentation: a review and update. Am J Physiol Imaging 7: 121–135PubMedGoogle Scholar
  54. Nahas GG (1986) Toxicolology and pharmacology. Nahas GG (ed) Marijuana in science and medicine. Raven, New York, p 109Google Scholar
  55. Nicolas JM, Catafau AM, Estruch R, Lomena FJ, Salamero M, Herranz R, Monforte R, Cardenal C, Urbano-Marquez A (1993) Regional cerebral blood flow-SPECT in chronic alcoholism: relation to neuropsychological testing. J Nucl Med 34: 1452–1459PubMedGoogle Scholar
  56. Pappata S, Samson Y, Chavoix C, Prenant C, Maziere M, Baron JC (1988) Regional specific binding of [nC]RO 15 1788 to central type benzodiazepine receptors in human brain: quantitative evaluation by PET. J Cereb Blood Flow Metab 8: 304–313CrossRefPubMedGoogle Scholar
  57. Reiter RJ (1985) Oxidative processes and antioxidative defense mechanisms in the aging. FASEB J 9: 526–533Google Scholar
  58. Rogers LW, Ackermann RJ (1992) SPECT instrumentation. Am J Physiol Imaging 7: 105–120PubMedGoogle Scholar
  59. Sachs H, Russell JAG, Christman DR, Cook B (1987) Alteration of regional cerebral glucose metabolic rate in non-Korsakoff chronic alcoholism. Arch Neurol 44: 1242–1251CrossRefPubMedGoogle Scholar
  60. Samson Y, Baron JC, Feline A, Bories J, Crouzel C (1986) Local cerebral glucose utilization in chronic alcoholics: a positron tomographic study. J Neurol Neurosurg Psychiatry 49: 11651170CrossRefGoogle Scholar
  61. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977) The 14C deoxyglucose method for the measurement of local cerebral glucose utilization: the conscious and anesthetized albino rat. J Neurochem 28: 897–916CrossRefPubMedGoogle Scholar
  62. Stapleton JM, Henningfield JE, Wong DF, Phillips RL, Grayson RF, Dannais RF, London ED (1993) Nicotine reduces cerebral glucose utilization in humans. NIDA Res Monogr 132: 106Google Scholar
  63. Sybirska E, Seibyl JP, Bremner JD, Baldwin RM, Al-Tikriti MS, Bradberry C, Malison RT, Zea Ponce Y, Zoghbi S, During M, Goddard AW, Woods SW, Hoffer PB, Charney DS, Innis RB (1993) [123-I]Iomazenil SPECT imaging demonstrates significant benzodiazepine receptor reserve in human and non human primate brain. Neuropharmacology 32: 671–680CrossRefPubMedGoogle Scholar
  64. Theodore WH, DiChiro G, Margolin R, Fishbein D, Porter RJ, Brooks RA (1986) Barbiturates reduce human cerebral glucose metabolism. Neurology 36: 60–64CrossRefPubMedGoogle Scholar
  65. Tiihonen J, Kuikka J, Bergström K, Hakola P, Larhu J, Ryynänen OP, Föhr J (1995) Altered striatal dopamine re-uptake site densities in habitual violent and non-violent alcoholics. Nature Med 1: 654–657CrossRefPubMedGoogle Scholar
  66. Tunving K, Thulin S, Risberg J, Warkentin S (1986) Regional cerebral blood flow in long term heavy cannabis use. Psychiatry Res 17: 15–21CrossRefPubMedGoogle Scholar
  67. Volkow ND, Fowler JS (1992) Neuropsychiatric disorders: investigation of schizophrenia and substance abuse. Semin Nucl Med XXII: 254–267Google Scholar
  68. *Volkow ND, Mullani N, Gould KL, Adler S, Krajewski K (1988a) Cerebral blood flow in chronic cocaine users: a study with positron emission tomography. Br J Psychiatry 152: 641–648CrossRefPubMedGoogle Scholar
  69. Volkow ND, Guynn R, Marani S, Adler S, Gould L (1988b) Effects of alcohol on cerebral blood flow. Psychiatry Res 24: 201–209CrossRefPubMedGoogle Scholar
  70. Volkow ND, Fowler JS, Wolf AP, Schlyer D, Shiue C-Y, Dewey SL, Alpert R, Logan J, Christman D, Bendriem B, Hitzemann R, Henn F (1990a) Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry 147: 719–724PubMedGoogle Scholar
  71. Volkow ND, Hitzemann R, Wolf AP, Logan J, Fowler JS, Christman D, Dewey SL, Schlyer D, Burr G, Vitkun S, Hirschowitz J (1990b) Acute effects of ethanol on regional brain glucose metabolism and transport. Psychiatry Res 35: 39–48CrossRefPubMedGoogle Scholar
  72. Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey SL, Bendriem B, Alpert R, Hoff A (1991a) Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 148: 621–626PubMedGoogle Scholar
  73. Volkow ND, Gillespie H, Mullani N, Tancredi L, Grant L, Ivanovic M, Hollister L (1991b) Cerebellar metabolic activation by delta-9-tetrahydrocannabinol in human brain: a study with positron emission tomography and F-18–2-fluoro-2-deoxyglucose. Psychiatry Res 40: 69–78CrossRefPubMedGoogle Scholar
  74. Volkow ND, Fowler JS, Wolf AP, Wang G-J, Logan J, MacGregor R, Dewey SL, Schlyer DJ, Hitzemann R (1992a) Distribution of 11C-cocaine in human heart, lungs, liver and adrenals. A dynamic PET study. J Nucl Med 33: 521–525PubMedGoogle Scholar
  75. Volkow, ND, Hitzemann R, Wang G-J (1992b) Decreased brain metabolism in neurologically intact healthy alcoholics. Am J Psychiatry 149: 1016–1022PubMedGoogle Scholar
  76. Volkow ND, Hitzemann R, Wang G-J, Fowler JS, Wolf AP, Dewey SL (1992c) Long-term frontal brain metabolic changes in cocaine abusers. Synapse 11: 184–190CrossRefPubMedGoogle Scholar
  77. Volkow ND, Wang G-J, Hitzemann R, Fowler JS, Wolf AP, Pappas N, Biegon A, Dewey SL (1993a) Decreased cerebral response to inhibitory neurotransmission in alcoholics. Am J Psychiatry 150: 417–422PubMedGoogle Scholar
  78. Volkow ND, Fowler JS, Wang G-J, Hitzemann R, Logan J, Schlyer D, Dewey DL, Wolf AP (1993b) Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14: 169–177CrossRefPubMedGoogle Scholar
  79. Volkow ND, Wang G-J, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, MacGregor R, Burr G, Cooper T, Wolf AP (1994a) Imaging endogeneous dopamine competition with [11C]raclopride in the human brain. Synapse 16: 255–262CrossRefPubMedGoogle Scholar
  80. Volkow ND, Wang G-J, Hitzemann R, Fowler JS, Overall JE, Burr G, Wolf AP (1994b) Recovery of brain glucose metabolism in detoxified alcoholics. Am J Psychiatry 151: 178–183PubMedGoogle Scholar
  81. Volkow ND, Wang G-J, Hitzemann R, Fowler JS, Pappas N, Loremier P, Burr G, Pascani K, Wolf AP (1995a) Depression of thalamic metabolism by lorazepam is associated with sleepiness. J Neuropsychopharmacol 12: 123–132CrossRefGoogle Scholar
  82. **Volkow ND, Ding U, Fowler JS, Wang G-J, Logan J, Gatley SJ, Dewey SL, Ashby C, Lieberman J, Hitzemann R, Wolf AP (1995b) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch Gen Psychiatry 52: 456–463CrossRefPubMedGoogle Scholar
  83. Volkow ND, Fowler JS, Logan J, Gatley SJ, Dewey SL, MacGregor RR, Schlyer DJ, Pappas N, King P, Wolf AP (1995c) Carbon-11-cocaine binding compared at sub-pharmacological and pharmacological doses: A PET study. J Nucl Med 36: 1289–1297PubMedGoogle Scholar
  84. Volkow ND, Wang G-J, Begleiter H, Hitzemann R, Pappas N, Burr G, Pascani K, Wong C, Fowler JS, Wolf AP (1995d) Regional brain metabolic response to lorazepam in subjects at risk for alcoholism. Alcohol Clin Exp Res 19: 510–516CrossRefPubMedGoogle Scholar
  85. Volkow ND, Wang G-J, Fowler JS, Logan J, Hitzemann R, Gatley SJ, MacGregor RR, Wolf AP (1996a) Cocaine binding is decreased in the brain of detoxified cocaine abusers. J Neuropsychopharmacol 14: 159–168CrossRefGoogle Scholar
  86. Volkow ND, Gillespie H, Mullani N, Tancredi L, Grant C, Valentine A, Hollister L (1996b) Brain glucose metabolism in chronic marijuana users during baseline and during marijuana intoxication. Psychiatry Res 67: 29–38CrossRefPubMedGoogle Scholar
  87. Wang G-J, Volkow ND, Fowler JS, Wolf AP, Ferrieri R, Schlyer DJ, Alexoff D, Pappas N, Lieberman J, King P, Warner D, Wong C, Hitzemann RJ (1994) Methylphenidate decreases regional cerebral blood flow in normal human subjects. Life Sci 54: PL143–146CrossRefPubMedGoogle Scholar
  88. Weber DA, Franceschi D, Ivanovic M et al. (1993) SPECT and planar brain imaging in crack abuse: iodine-123-iodoamphetamine uptake and localization. J Nucl Med 34: 899–907PubMedGoogle Scholar
  89. Wik G, Borg S, Sjögren I, Wiesel F, Blomquist G, Borg J, Greitz T, Nybäck H, Sedvall G, Stone Elander S, Widen L (1988) PET determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11Cglucose. Acta Psychiatrica Scand 78: 234–241CrossRefGoogle Scholar
  90. Wilens TE, Biederman J (1992) The stimulants. Pediatr Psychopharmacol 15: 191–222Google Scholar
  91. Wolkin A, Angrist B, Wolf A, Brodie J, Jordan B, Jaeger J, Cancro R, Rotrosen J (1987) Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography. Psychopharmacology 92: 241–246CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • N. D. Volkow
  • J. S. Fowler
  • G.-J. Wang

There are no affiliations available

Personalised recommendations